1st Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$84,512
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY-2015 Labor-HHS Appropriations Bills. Advocacy for enhanced funding of the Biomedical Advanced Research and Development Authority (BARDA) at HHS, funding of the Project BioShield Special Reserve Fund (SRF) for acquisition of medical countermeasure against biological and chemcial threats, and the funding related to pandemic influenza. Education of Members of Congress and their staff on a recombinant protective antigen (rPA) anthrax vaccine.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: SENATE; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.